Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Succinylated gelatin + multiple electrolytes + sodium acetate is a physiologically balanced colloid solution used for fluid resuscitation and plasma volume expansion. It contains 4% succinylated gelatin (modified fluid gelatin) in a balanced electrolyte carrier that includes sodium, potassium, magnesium, and chloride, with sodium acetate acting as a metabolic buffer. Unlike older gelatin formulations based on 0.9% sodium chloride, this balanced version is designed to prevent hyperchloremic metabolic acidosis and maintain electrolyte homeostasis during the treatment of hypovolemia and shock. The gelatin component provides immediate intravascular volume expansion by increasing plasma oncotic pressure, while the electrolyte and acetate components support acid-base balance and physiological ion concentrations. The First Affiliated Hospital of Guangzhou Medical University has been involved in the clinical development and evaluation of this formulation for managing hypovolemic conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on succinylated gelatin + multiple electrolytes + sodium acetate.